""We note with satisfaction that the report does not call the patent system into question, but focuses on the way in which companies make use of patents in the pharmaceutical market. The EPO holds the view that a well-functioning patent system is vital for a sound competition environment", stated EPO President Alison Brimelow. "The Office welcomes the fact that the findings of the report help us to better understand the drivers for the behaviour of the actors in the patent system." The report repeatedly calls for the creation of a centralised European patent judiciary and above all, a Community patent to do away with some of the most obvious shortcomings of the present European patent system, a stance which the EPO wholeheartedly endorses. Moreover, the EPO welcomes the report as it provides further insight into applicant behaviour, bringing support to some of the Office's initiatives intending to safeguard or increase the quality of European patents, such as "Raising the bar", to introduce stricter rules related to the filing of divisional applications."